CLEVELAND, Aug. 11, 2022 /PRNewswire/ -- ViewRay, Inc. (MRXC) (NASDAQ: VRAY) today announced that the National Cancer Center Hospital (NCCH) of Japan has upgraded its original Cobalt MRIdian® ...
MIRAGE phase III randomized controlled trial shows a significant reduction in GU and GI toxicities with MRIdian® MRI-guided versus CT-guided SBRT DENVER, Jan. 12, 2023 /PRNewswire/ -- ViewRay, Inc.
Represents Second VA Hospital to Offer MRIdian MRI-guided Radiation Therapy Cancer Treatment Directly to Veterans "We are proud to be working with VA Ann Arbor Healthcare System, a dedicated group of ...
From Laura Bassi to Marie Curie, for centuries, women have been making important contributions to the world of physics. Now with ViewRay’s MRIdian system, women are leading the charge in bringing the ...
MIRAGE phase III randomized controlled trial shows a significant reduction in GU and GI toxicities with MRIdian® MRI-guided versus CT-guided SBRT More notably, there were improvements in multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results